By Barry C. Fox, M.D., University of WisconsinAntibodies are one of the main components of the adaptive immune system. (Image: Kateryna Kon/Shutterstock)The Concept of the Adaptive Immune System
The adaptive immune system is composed of highly specialized cells that adapt to and learn from prior invaders. This is a system that remembers, for example, that someone had measles as a child, and will protect the body for a lifetime against measles.
The adaptive system has two major branches, the cell-mediated system, and the antibody-mediated humoral system. Note that humor is an old word that describes body fluidslike lymph and blood.
Lymphocytes, one of the five types of white blood cells, carry out the immune responses in both branches of the adaptive system. Lymphocytes are divided into B-cells and T-cells.
Fetal primitive stem cells that continue to mature in the bone marrow become B-cells. Others complete their growth in the thymus and become T-cells. Importantly, each B- and T-cell is specific only for one antigen, hence, they can only bind to one particular molecular structure.
Note that antigen is short for antibody generator, and represents any foreign substance. Macrophages are another type of white blood cellwith macro meaning big, and phages meaning eater. They are present in essentially all tissues of the body and are critical in both innate and adaptive immunity.
This is a transcript from the video series An Introduction to Infectious Diseases. Watch it now, on The Great Courses Plus.
B-cells work in the humoral immune system to mount a very specific antigen response. B-cells can also inactivate viruses by neutralizing them before they can enter host cells. Some B-cells become memory cells, allowing a quicker, more specific immune response the next time the body encounters the same infection.
T-cells, on the other hand, are part of a cell-mediated immune response and can be divided further into T-helper cells and cytotoxic T-cells. In the case of HIV or human immunodeficiency virus, the virus replicates rapidly and destroys the T-helper cells, resulting in more infected than healthy cells.
Cytotoxic T-cells attempt to destroy the HIV virus, but over time, the bodys ability to fight off infection is severely depletedmaking people with HIV highly susceptible to infections. T-cells also activate B-cells, and they can destroy microbes that are inside cells. Some T-cells also transform into memory cells so that they will recognize an invader if it ever attacks again.
Learn more about tick-borne diseasesa public health menace.
Antibodies are the other major component of the humoral system. Antibodies are produced by B lymphocytes that have matured into plasma cells. They can perform several functions, including neutralizing bacterial toxins, binding to viruses to prevent entry into cells, and opsonization in which a coating of antibodies increases the effectiveness of neutrophils trying to engulf bacteria.
Antibodies are analogous to the pincers of insects and are generally Y-shaped. There are four major categories of antibodiesimmunoglobulins M, A, E, and G.
IgM is a very large protein that clears foreign substances from the bloodstream. IgM antibodies are part of the bodys general first line of defense against invaders.
IgA is found in the secretions of the saliva and mucous. An IgA provides a mucosal first line of defense.
IgE is involved in immediate allergic responses, and sometimes, parasitic infections. IgE combines with a special cell known as a mast cell to release a chemical called histamine, which leads to swelling.
Finally, the most important immunoglobulin is IgG. IgG antibodies are formed in response to specific invaders, and they usually last a lifetime. They do take 714 days to be produced.
Learn more about how vaccines save lives.
IgG antibodies are produced in response to vaccination, but the two-week delay explains why it cannot be used as an immediate treatment strategy for infection. However, during the Ebola outbreak, another use of antibodies was testedafter the treatment and cure of the first American who had Ebola, doctors used the antibodies from his blood as a way to treat other patients with the Ebola virus.
The antibodies were transfused into newly infected patients in a process called passive immunizationproviding immediate antibodies instead of waiting two weeks. A similar process is utilized after some tetanus exposures.
For those individuals who have unusually severe allergies, immunotherapy is also possible. This treatment involves the intentional introduction of foreign allergic antigensunder medical supervisionto decrease IgE and increase IgG and IgA production. The net result is an improvement in allergy symptoms.
Learn more about bioterrorism and how worried we should be.
When a child gets the live measles vaccine, what happens after vaccination? The vaccine with measles antigens stimulates B-cells to mature into either an antibody-secreting plasma cell (producing IgM and IgG antibodies) or memory B-cells.
This is also known as the primary immune response. The antibody levels will gradually decline once the threat is over, but the memory B-cells remain dormant and present in the lymphatic system.
If the individual contracts the measles virus again as an adult, similar to waking a bear out of hibernation, the cells will rapidlywithin hoursstart producing large amounts of measles-specific IgG antibodies. Antibodies will attach themselves to the virus before they can attack healthy body cells. The memory immune lymphocytes would also recognize a pathogenic germ and assist in its destruction.
The adaptive immune system consists of specialized cells that adapt to and learn from previous invaders. For instance, this system remembers that someone had measles when they were a child, and when/if the same virus attacks their body again, this system will protect them.
Antibodies are a major component of the humoral immune system. The four major categories of antibodies are IgM, IgA, IgE, and IgG, with each one having a different function. Ig is short for immunoglobulins.
IgE is a significant antibody in the adaptive immune system. IgE is involved in immediate allergic responses, and sometimes, parasitic infections. IgE combines with a special cell known as a mast cell to release a chemical called histamine, which leads to swelling.
Read more:
The Adaptive Immune System: Cellular & Humoral Immunity - The Great Courses Daily News
- Different Types Of Stem Cells: Embryonic Vs. Adult ... - January 17th, 2025
- Rejuvenation of Aging Adult Stem Cells to Improve their Regenerative Potential - Frontiers - January 13th, 2025
- Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis - Business... - December 22nd, 2024
- What Are Stem Cells? Biomedical Beat Blog National Institute of ... - November 29th, 2024
- TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs - Veterans Affairs - November 8th, 2024
- Understanding Mature Tissue or Organ Stem Cells and Their Clinical ... - November 8th, 2024
- Biology of stem cells: an overview - PMC - PubMed Central (PMC) - October 30th, 2024
- New government tech deals boost the business of cancer detection - GOV.UK - October 11th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Yahoo News UK - October 11th, 2024
- Advances in different adult stem cell-derived exosomal non-coding RNAs for the treatment of neurological disorders: a narrative review - Frontiers - September 26th, 2024
- Breakthrough technique may help speed understanding, treatment of MD, ALS - Harvard Gazette - September 14th, 2024
- Rostock University Explores Use of Stem Cells for Meat Cultivation with Help from Innocent Meat - vegconomist - the vegan business magazine - August 12th, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Targeting the stem cell niche micro-environment as therapeutic strategies in aging - Frontiers - June 28th, 2024
- International trial introduces another curative option for sickle cell disease - EurekAlert - June 28th, 2024
- HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation - Frontiers - June 28th, 2024
- Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and... - June 21st, 2024
- Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management - June 21st, 2024
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. - June 21st, 2024
- Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer - June 21st, 2024
- API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines - June 21st, 2024
- Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems - June 21st, 2024
- Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform - June 21st, 2024
- Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog... - June 21st, 2024
- Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting - June 21st, 2024
- Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing - June 21st, 2024
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran - June 21st, 2024
- Idorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’... - June 21st, 2024
- Radiopharm Receives Strategic Investment for up to A$18 million - June 21st, 2024
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee - June 21st, 2024
- Trading by management and close relations of management - June 21st, 2024
- Major shareholder announcement - June 21st, 2024
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 21st, 2024
- Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell - Retraction Watch - June 19th, 2024
- Shares of Biotech MicroCap Rip on Licensing Talks - The Globe and Mail - June 15th, 2024
- Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 - May 23rd, 2024
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23rd, 2024
- Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist... - May 23rd, 2024
- Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus... - May 23rd, 2024
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 - May 23rd, 2024
- New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of... - May 23rd, 2024
- Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients - May 23rd, 2024
- Kane Biotech Announces First Quarter 2024 Financial Results - May 23rd, 2024
- Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast - May 23rd, 2024
- Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy - May 23rd, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - May 23rd, 2024
- 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - May 23rd, 2024
- Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - May 23rd, 2024
- Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024 - May 23rd, 2024
- Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences - May 23rd, 2024
- NANOBIOTIX to Present at the Jefferies Global Healthcare Conference - May 23rd, 2024
- Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual... - May 23rd, 2024
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
Recent Comments